Kiniksa Pharmaceuticals International Plc (KNSA)
46.16
+0.14
(+0.30%)
USD |
NASDAQ |
Mar 06, 16:00
46.24
+0.08
(+0.17%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International SG&A Expense (TTM) : 196.27M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.365M |
| NovoCure Ltd. | 417.73M |
| LivaNova Plc | 553.37M |
| Alterola Biotech, Inc. | -- |
| Akanda Corp. | 1.080M |